The added diagnostic value of five different C-reactive protein point-of-care test devices in detecting pneumonia in primary care: A nested case-control study

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 75, Issue 4, 2015, Pages 291-295

  Minnaard, Margaretha C ^a   Van De Pol, Alma C ^a   De Groot, Joris A H ^a   De Wit, Niek J ^a   Hopstaken, Rogier M ^b   Van Delft, Sanne ^b   Goossens, Herman ^c   Ieven, Margareta ^c   Lammens, Christine ^c   Little, Paul ^d   Butler, Chris C ^e   Broekhuizen, Berna D L ^a   Verheij, Theo J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b SALTRO   (Netherlands)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^e CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

C reactive protein; Diagnostic tests; Lower respiratory tract infections; Point of care testing; Primary health care

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ANALYZER; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; COUGHING; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EUROPE; FEMALE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; POINT OF CARE TESTING; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; AGED; BLOOD; COMPARATIVE STUDY; EVALUATION STUDY; METABOLISM; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PNEUMONIA; POINT-OF-CARE TESTING; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 84928795356     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2015.1006136     Document Type: Article

References (15)

1. Almirall J, Bolibar I, Toran P, Pera G, Boquet X, Balanzo X, Sauca G. Contribution of C- reactive protein to the diagnosis and assessment of severity of community-Acquired pneumonia. Chest. 2004; 125: 1335-42
2. Flanders S A, Stein J, Shochat G, Sellers K, Holland M, Maselli J, Drew WL, Reingold AL, Gonzales R. Performance of abedside C-reactive protein test in the diagnosis of community-Acquired pneumonia in adults with acute cough. Am J Med. 2004; 116: 529-35
3. holm A, Pedersen SS, Nexoe J, Obel N, Nielsen LP, Koldkjaer O, Pedersen C. Procalcitonin versus C-reactive protein for predicting pneumonia in adults with lower respiratory tract infection in primary care. Br JGen Pract. 2007; 57: 555-60
4. Melbye H, Straume B, Brox J. Laboratory tests for pneumonia in general practice: the diagnostic values depenDon the duration of illness. Scand JPrim Health Care. 1992; 10: 234-40
5. Pepys M B, Hirschfield G M. C -reactive protein: acritical update. J Clin Invest. 2003; 111: 1805-12
6. van Vugt SF, Broekhuizen BD, Lammens C, Zuithoff NP, de Jong PA, Coenen S, Ieven M, Butler CC, Goossens H, Little P, Verheij TJ. Use of serum Creactive protein and procalcitonin concentrations in addition to sympt'oms and signs to predict pneumonia in patients presenting to primary care with acute cough: diagnostic study. BMJ. 2013; 346: f2450
7. Minnaard MC, van de Pol AC, Broekhuizen BD, Verheij T J, Hopstaken RM, van Delft S, Kooijman-Buitink AM, de Groot JA, de Wit NJ. Analytical performance, agreement and user-friendliness of fi ve C-reactive protein point-of-care tests. Scan J Clin Lab Invest. 2013; 73: 627-34
8. Moons KG. Criteria for scientifi cevaluation of novel markers: aperspective. Clin Chem. 2010; 56: 537-41
9. Nuttall J, Hood K, Verheij T J, Little P, Brugman C, Veen RE, Goossens H, Butler CC. Building an international network for aprimary care research program: refl ections on challenges and solutions in the set-up and delivery of aprospective observational study of acute cough in 13 European countries. BMC Fam Pract. 2011; 12: 78
10. Biesheuvel CJ, Vergouwe Y, Oudega R, Hoes A W, Grobbee DE, Moons KG. Advantages of the nested case-control design in diagnostic research. BMC Med Res Methodol. 2008; 8: 48
11. Cals J W, Butler CC, Hopstaken RM, Hood K, Dinant GJ. Effect of point of care testing for Creactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. BMJ. 2009; 338: b1374
12. Falk G, Fahey T. C -reactive protein and community-Acquired pneumonia in ambulatory care: systematic review of diagnostic accuracy studies. Fam Pract. 2009; 26: 10-21
13. hopstaken R M, Muris J W, Knottnerus J A, Kester AD, Rinkens PE, Dinant GJ. Contributions of symptoms, signs, erythrocyte sedimentation rate, and C-reactive protein to adiagnosis of pneumonia in acute lower respiratory tract infection. Br JGen Pract. 2003; 53: 358-64
14. Verheij TJM, Hopstaken RM, Prins JM, SaloméPhL, Bindels PJ, Ponsioen BP, Sachs APE, Thiadens HA, Verlee E. The NHG-Guideline acute cough. Huisarts Wet. 2011; 68-92
15. Monteny M, ten Brinke MH, van BJ, de Rijke YB, Berger MY. Point-of-care C-reactive protein testing in febrile children in general practice. Clin Chem Lab Med. 2006; 44: 1428-32